ECSP10010607A - 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS - Google Patents

2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS

Info

Publication number
ECSP10010607A
ECSP10010607A EC2010010607A ECSP10010607A ECSP10010607A EC SP10010607 A ECSP10010607 A EC SP10010607A EC 2010010607 A EC2010010607 A EC 2010010607A EC SP10010607 A ECSP10010607 A EC SP10010607A EC SP10010607 A ECSP10010607 A EC SP10010607A
Authority
EC
Ecuador
Prior art keywords
syk
jak
inhibitors
kinasas
carboxamids
Prior art date
Application number
EC2010010607A
Other languages
Spanish (es)
Inventor
Shawn M Bauer
Anjali Pandey
Zhaozhong J Jia
Yonghong Song
Qing Xu
Mukund Mehrotra
Jack W Rose
Wolin Huang
Chandrasekar Venkataramani
Original Assignee
Portola Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/002420 external-priority patent/WO2009145856A1/en
Application filed by Portola Pharm Inc filed Critical Portola Pharm Inc
Publication of ECSP10010607A publication Critical patent/ECSP10010607A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se dirige a compuestos de la Fórmula I-II y tautómeros, sales o estereoisómeros farmacéuticamente aceptables de la misma que son inhibidores de syk y/o JAK quinasas. La presente invención también se dirige a intermediarios usados para realizar dichos compuestos, a la preparación de dicho compuesto, composiciones farmacéuticas que contienen dicho compuesto, métodos de inhibición de syk y/o JAK quinasa, métodos para la inhibición de agregación de plaquetas, y métodos para evitar o tratar una cantidad de enfermedaddes mediadas, al menos en parte, por la actividad syk y/o JAK quinasa, como por ejemplo trombosis y Linfoma no- Hodgkin.The present invention is directed to compounds of Formula I-II and pharmaceutically acceptable tautomers, salts or stereoisomers thereof which are inhibitors of syk and / or JAK kinases. The present invention is also directed to intermediates used to make said compounds, to the preparation of said compound, pharmaceutical compositions containing said compound, methods of inhibition of syk and / or JAK kinase, methods for inhibition of platelet aggregation, and methods to avoid or treat a number of diseases mediated, at least in part, by the syk and / or JAK kinase activity, such as thrombosis and non-Hodgkin lymphoma.

EC2010010607A 2008-04-16 2010-11-15 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS ECSP10010607A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4539908P 2008-04-16 2008-04-16
US4541708P 2008-04-16 2008-04-16
US4540608P 2008-04-16 2008-04-16
US12034108P 2008-12-05 2008-12-05
US12034808P 2008-12-05 2008-12-05
PCT/US2009/002420 WO2009145856A1 (en) 2008-04-16 2009-04-16 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors

Publications (1)

Publication Number Publication Date
ECSP10010607A true ECSP10010607A (en) 2011-02-28

Family

ID=44279986

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010607A ECSP10010607A (en) 2008-04-16 2010-11-15 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP10010607A (en)

Similar Documents

Publication Publication Date Title
DOP2010000310A (en) 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS
EA201001618A1 (en) INHIBITORS SYK PROTEINKINAZ
NI201000176A (en) 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDES AS INHIBITORS OF SYK OR JAK KINASES.
DOP2019000010A (en) COMPOUND (R) -N- (5-CHLORINE-1- (3,3-DIFLUORO-1- (OXETAN-3-IL) PIPERIDIN-4-IL) -1H-PIRAZOL-4-IL) -4-ETOXI- 7H-PIRROLO [2,3-D] PYRIMIDIN-2-AMINA OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME
BR112015028501B8 (en) BIPYRAZOLE DERIVATIVE COMPOUNDS, THEIR SALTS, COMPOSITION COMPRISING THE COMPOUND OR THE SALT, METHOD FOR IN VITRO INHIBITION OF A JAK1 ACTIVITY, AND PROCESS FOR PREPARING PHOSPHORIC ACID SALT
BR112014004504A2 (en) "compound as c-kit kinase inhibitor, its use, pharmaceutical composition, and medicament for the treatment of a kinase mediated disease"
WO2009131687A3 (en) Inhibitors of protein kinases
ECSP12011645A (en) JAK DE PIRAZOLOPIRIMIDINA INHIBITING COMPOUNDS AND METHODS
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
MX386542B (en) 2,3-DIHYDRO-ISOINDOL-1-ONE DERIVATIVES, AS BTK KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM.
CO6440596A2 (en) 3 KINASE PHOSFOINOSITI INHIBITORS AND / OR RAPAMYCIN MAMMAL OBJECTIVE
CO7160119A2 (en) Imidazo [1,2-b] pyridazine derivatives as a kinase inhibitor
BR112018008966A2 (en) jak kinase inhibitor compounds for the treatment of respiratory disease
DOP2010000309A (en) 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS
TR201802944T4 (en) DERIVATIVES OF AZAINDAZOL OR DIAZAINDAZOL
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
CO7131360A2 (en) Novel substituted cyclic n-pyridinyl amides as kinase inhibitors
CU24039B1 (en) IMIDAZOLIDIN-2-ONA 1,3-DISPOSED DERIVATIVES AS CYP17 INHIBITORS
EA201500182A1 (en) 4-METHYL-2,3,5,9,9b-PENTAASACYCLOPENT [a] NAFTAIL
BR112013016595A2 (en) neprilysin inhibitors
DOP2013000243A (en) ACETIL-COA CARBOXILASA REPLACED INHIBITORS
BR112012008147A2 (en) heteroaryl compounds as kinase inhibitors
ECSP13012494A (en) OXADIAZOL INHIBITORS OF LEUCOTRENE PRODUCTION.
BR112013017362A2 (en) compound of formula (i), process for preparing a compound of formula (i), pharmaceutical composition and innovative compounds, methods and uses
MX2015017512A (en) COMPOUNDS 2,3-DIHIDROBENZOFURAN-5-ILICOS AS DYRK KINASE INHIBITORS.